Cargando…

Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current Status

Nonalcoholic fatty liver disease (NAFLD) is one of the major and prevalent liver diseases from the national and global perspectives. It appears that considerable numbers of the general population have been suffering from NAFLD. When a patient with NAFLD also exhibits inflammation of the liver, the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Partho Pratik, Mahtab, Mamun Al, Rahim, Mohammad Abdur, Yesmin, SM Sabrina, Islam, Sunan Bin, Akbar, Sheikh Mohammad Fazle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681570/ https://www.ncbi.nlm.nih.gov/pubmed/36466097 http://dx.doi.org/10.5005/jp-journals-10018-1360

Ejemplares similares

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
por: Rodrigues, Pedro M, et al.
Publicado: (2017)

miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
por: Rodrigues, Pedro M, et al.
Publicado: (2017)

Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
por: Noor-E-Alam, Mohammad, et al.
Publicado: (2016)

Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
por: Goto, Toshihiro, et al.
Publicado: (2018)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2019)

Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice
por: Zhuge, Aoxiang, et al.
Publicado: (2022)

The Journal in the Horizon of Asia and Europe
por: Fazle Akbar, Sheikh Mohammad, et al.
Publicado: (2018)

Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

Hepatic Venous Pressure Gradient Measurement in Bangladeshi Cirrhotic Patients: A Correlation with Child’s Status, Variceal Size, and Bleeding
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)

Healthcare for non-Covid-19 liver disease patients during the Covid-19 pandemic in Bangladesh: Current trend and future implications
por: Faizul Huq, A. K. M., et al.
Publicado: (2020)

Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time
por: Al-Mahtab, Mamun, et al.
Publicado: (2020)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers
por: Khan, Md Sakirul Islam, et al.
Publicado: (2020)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Tele-education for hepatology residents in Bangladesh during the Covid-19 pandemic
por: Mahtab, Mamun A., et al.
Publicado: (2020)

Plasma Exchange in Patients of Acute on Chronic Liver Failure: An Observational Study in Bangladesh
por: Mukit, Abdullah Al, et al.
Publicado: (2022)

Unprecedented rise of monkeypox in Europe and America: Are Asian countries ready for a new outbreak during the ongoing COVID-19 pandemic?
por: Khan, Sakirul, et al.
Publicado: (2022)

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon
por: Al-Mahtab, Mamun, et al.
Publicado: (2023)

Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis
por: Belopolsky, Yuliya, et al.
Publicado: (2020)

Alarming Levels of Hepatitis C Virus Prevalence among Rohingya Refugees in Bangladesh: Emergency National and International Actions Warranted
por: Mahtab, Mamun Al, et al.
Publicado: (2019)

Recent downhill course of COVID-19 at Rohingya refugee camps in Bangladesh: Urgent action solicited
por: Khan, Sakirul, et al.
Publicado: (2021)

Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic
por: Khan, Sakirul, et al.
Publicado: (2022)

A Dynamic Mathematical Modeling Revelation about the Impact of Vaccination on Hepatitis B Virus-induced Infection and Death Rate in Bangladesh
por: Chakraborty, Sajib, et al.
Publicado: (2019)

Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice
por: Li, Wen-Cong, et al.
Publicado: (2021)

Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
por: Li, Shengjie, et al.
Publicado: (2022)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

A new method to induce nonalcoholic steatohepatitis (NASH) in mice
por: Savari, Feryal, et al.
Publicado: (2019)

Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis
por: Giammarino, Alexa M., et al.
Publicado: (2021)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j8b33lvdlpsfq96kt7icguactl